BioMarin (BMRN) CTO reports 1,693-share tax withholding, holds 84,140
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BioMarin Pharmaceutical EVP and Chief Technical Officer Charles Greg Guyer reported a tax-related share disposition. On the transaction date, 1,693 shares of common stock were withheld at a price of $56.05 per share to cover tax obligations, a non‑market transaction. After this event, he directly held 84,140 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Guyer Charles Greg
Role
EVP, Chief Technical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,693 | $56.05 | $95K |
Holdings After Transaction:
Common Stock — 84,140 shares (Direct)
Footnotes (1)
FAQ
What did BioMarin (BMRN) executive Charles Greg Guyer report in this Form 4?
Executive Charles Greg Guyer reported a tax-related disposition of shares. 1,693 BioMarin common shares were withheld at $56.05 per share to satisfy tax obligations, and he continued to hold 84,140 shares directly after the transaction.
Was the BioMarin (BMRN) Form 4 transaction an open-market sale?
No, the Form 4 reflects tax withholding, not an open-market sale. Shares were delivered back to cover tax liabilities, coded as an F transaction, which is a non-market, administrative event rather than a discretionary sale of BioMarin stock.
What does transaction code F mean in the BioMarin (BMRN) Form 4 filing?
Transaction code F signifies payment of an exercise price or tax liability by delivering securities. In this BioMarin filing, it indicates that 1,693 common shares were withheld at $56.05 per share to satisfy Charles Greg Guyer’s tax obligations, not a market trade.